The Safety and Efficacy of Etanercept on Cardiac Functions and Lipid Profile in Patients With Active Rheumatoid Arthritis


ŞENEL S. , Cobankara V., Taskoylu O., Karasu U., KARAPINAR H. , ERDİŞ E. , ...Daha Fazla

JOURNAL OF INVESTIGATIVE MEDICINE, cilt.60, ss.62-65, 2012 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 60 Konu: 1
  • Basım Tarihi: 2012
  • Doi Numarası: 10.2310/jim.0b013e31823a00f4
  • Dergi Adı: JOURNAL OF INVESTIGATIVE MEDICINE
  • Sayfa Sayıları: ss.62-65

Özet

Objectives: Patients with rheumatoid arthritis (RA) are known to be at increased cardiovascular risk. Etanercept is a tumor necrosis factor alpha (TNF-alpha) blocking agent that has been successfully used in the treatment of RA. We sought to assess the effects of etanercept on cardiac functions and lipid profile in RA patients without overt cardiac disease.